# A Novel Parameter LIT/N That Predicts Survival in COVID-19 ICU Patients

> **NCT05520918** · NA · COMPLETED · sponsor: **Gazi University** · enrollment: 63 (actual)

## Conditions studied

- COVID-19 Pneumonia

## Interventions

- **DIAGNOSTIC_TEST:** the LIT test

## Key facts

- **NCT ID:** NCT05520918
- **Lead sponsor:** Gazi University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-30
- **Primary completion:** 2021-05-07
- **Final completion:** 2021-09-01
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2022-09-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05520918

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05520918, "A Novel Parameter LIT/N That Predicts Survival in COVID-19 ICU Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05520918. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*